However, statistically significant differences were observed in tumor T stage, lymph node metastasis, tumor necrosis, EGFR, and tumor markers, and in general, the higher expression of AGRN was more pronounced in patients with later stage and lymph node metastasis. The gene discussed is EGFR; the disease is metastatic malignant neoplasm in the lymph nodes.